Compound information
- Natural Products
- ZC2194825
- Molecular Formula
- C17H17N3O3S
- Molecular Weight
- 343.099062404 g/mol
- Structure
-
- IUPAC Name
- 1-(1,3-benzothiazol-2-yl)-3-[(3,4-dimethoxyphenyl)methyl]urea
- InChI
- InChI=1S/C17H17N3O3S/c1-22-13-8-7-11(9-14(13)23-2)10-18-16(21)20-17-19-12-5-3-4-6-15(12)24-17/h3-9H,10H2,1-2H3,(H2,18,19,20,21)
- InChI Key
- BLLRIMWOQUZPTB-UHFFFAOYSA-N
- SMILES
- COc1ccc(CNC(=O)Nc2nc3ccccc3s2)cc1OC
- Source
- ZINC000010037365
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 7 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 72.48 Å2 | LogP | 3.095 |
LogS | -4.481 | LogD | 3.599 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.186 | Pgp substrate | 0.198 |
HIA | 0.966 | F20 % | 0.989 |
F30 % | 0.142 | Caco-2 | -4.598 |
MDCK | -5.003 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.279 | PPB | 101.18 |
VD | 0.614 | Fu | 1.68 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.989 | CYP1A2 substrate | 0.857 |
CYP2A6 substrate | 0.606 | CYP2B6 substrate | 0.708 |
CYP2C19 inhibitor | 0.85 | CYP2C19 substrate | 0.934 |
CYP2C8 substrate | 0.836 | CYP2C9 inhibitor | 0.888 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.059 |
CYP2D6 substrate | 0.945 | CYP2E1 substrate | 0.968 |
CYP3A4 inhibitor | 0.877 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.542 | CL | 8.866 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.076 | Hepatotoxicity | 0.682 |
Mutagenicity | 0.398 | Rat Oral Acute Toxicity | 0.015 |
FDAMDD | 0.153 | Skin Sensitization | 0.649 |
Carcinogenicity | 0.491 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.507 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.878 | IGC50 | 3.376 |
LC50FM | 4.183 | LC50DM | 5.085 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.539 | NR-AR-LBD | 0.305 |
NR-AhR | 0.989 | NR-Aromatase | 0.029 |
NR-ER | 0.657 | NR-ER-LBD | 0.296 |
NR-PPAR-gamma | 0.442 | SR-ARE | 0.775 |
SR-ATAD5 | 0.78 | SR-HSE | 0.071 |
SR-MMP | 0.91 | SR-p53 | 0.681 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.